Using 140 pretreatment tumor biopsies and 8 human cervical cancer cell lines, we identified multiple defects in PI3K/AKT pathway genes, including both activating mutations in PIK3CA (E545K) and inactivating mutations in PTEN (R233*). This evidence concerns the gene PIK3CA and neoplasm.